We therefore assessed whether propofol can mitigate the isoflurane-induced caspase-3 activation in vitro (H4-APP and H4 naïve cells) and in vivo [neonatal wild-type (WT) and AD transgenic (Tg) mice]. Here, APP is linked to Alzheimer disease.